Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | INCB054329 |
Trade Name | |
Synonyms | INCB-054329 |
Drug Descriptions |
INCB054329 is BET inhibitor, which results in decreased expression of BET protein-regulated genes including MYC, potentially leading to decreased tumor cell proliferation (PMID: 30206163) |
DrugClasses | BET Inhibitor (Pan) 32 |
CAS Registry Number | 1628607-64-6 |
NCIT ID | C121948 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AZD1208 + INCB054329 | AZD1208 INCB054329 | 0 | 0 |
INCB053914 + INCB054329 | INCB053914 INCB054329 | 0 | 0 |
INCB054329 | INCB054329 | 0 | 1 |
INCB054329 + INCB059872 | INCB054329 INCB059872 | 0 | 0 |
INCB054329 + Itacitinib | INCB054329 Itacitinib | 0 | 0 |
INCB054329 + Pemigatinib | INCB054329 Pemigatinib | 0 | 0 |
INCB054329 + Ruxolitinib | INCB054329 Ruxolitinib | 0 | 0 |
INCB054329 + SGI-1776 | INCB054329 SGI-1776 | 0 | 0 |